Carl Dambkowski, the Chief Medical Officer of $APGE ($APGE), sold 6,665 shares of the company on 12-04-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 2.5% of their shares. Following this trade, they now own 260,798 shares of $APGE stock.
$APGE Insider Trading Activity
$APGE insiders have traded $APGE stock on the open market 25 times in the past 6 months. Of those trades, 0 have been purchases and 25 have been sales.
Here’s a breakdown of recent trading of $APGE stock by insiders over the last 6 months:
- MICHAEL THOMAS HENDERSON (Chief Executive Officer) has traded it 12 times. They made 0 purchases and 12 sales, selling 165,000 shares.
- CARL DAMBKOWSKI (Chief Medical Officer) has traded it 12 times. They made 0 purchases and 12 sales, selling 39,990 shares.
- JANE HENDERSON (Chief Financial Officer) sold 6,000 shares.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$APGE Hedge Fund Activity
We have seen 74 institutional investors add shares of $APGE stock to their portfolio, and 96 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP added 1,267,451 shares (+35.7%) to their portfolio in Q3 2024
- DARWIN GLOBAL MANAGEMENT, LTD. removed 832,198 shares (-100.0%) from their portfolio in Q2 2024
- BRAIDWELL LP removed 748,816 shares (-31.3%) from their portfolio in Q3 2024
- WAYPOINT CAPITAL ADVISORS, LLC added 627,089 shares (+inf%) to their portfolio in Q3 2024
- JANUS HENDERSON GROUP PLC added 458,157 shares (+4018.9%) to their portfolio in Q3 2024
- POINT72 ASSET MANAGEMENT, L.P. added 438,036 shares (+162.7%) to their portfolio in Q3 2024
- DRIEHAUS CAPITAL MANAGEMENT LLC added 415,737 shares (+19.6%) to their portfolio in Q3 2024
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
